The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats
Abstract
The study objective was to investigate the effects of melatonin on obesity and obesity‐associated systolic hypertension and dyslipidemia in young male Zucker diabetic fatty (ZDF) rats, an experimental model of the metabolic syndrome. ZDF rats (n = 30) and lean littermates (ZL) (n = 30) were used. At 6 wk of age, both lean and fatty animals were subdivided into three groups (n = 10): naive (N), vehicle‐treated (V), and melatonin‐treated (M) (10 mg/kg/day) for 6 wk. Vehicle and melatonin were added to the drinking water. Melatonin reduced mean weight gain (51 ± 2/100 g BW) versus N‐ZDF group (58 ± 3, P < 0.05) without food intake differences. M‐ZDF rats showed an apparent reduction in systolic hypertension that proved not to be statistically significant, and a significant improvement in dyslipidemia, with a reduction in hypertriglyceridemia from 580 ± 40 to 420.6 ± 40.9 mg/dL (P < 0.01). Melatonin raised high‐density‐lipoprotein (HDL) cholesterol in ZDF (from 81.6 ± 4.9 to 103.1 ± 4.5 mg/dL, P < 0.01) and ZL rats (from 62.8 ± 4.8 to 73.5 ± 4.8 mg/dL, P < 0.05) and significantly reduced low‐density‐lipoprotein (LDL) cholesterol in ZDF rats from 5.20 ± 0.4 to 4.14 ± 0.3 mg/dL (P < 0.05) but had no effect on total cholesterol levels. To our knowledge, this is the first evidence of a positive effect of melatonin on overweight and lipid pattern of obese Zucker diabetic rats, supporting the proposition that melatonin administration may ameliorate overweight and lipid metabolism in humans. Because these benefits occurred in youth, before advanced metabolic and vascular complications, melatonin might help to prevent cardiovascular disease associated with obesity and dyslipidemia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension
Scheer, F. A. J. L., Van Montfrans, G. A., van Someren, E. J. W., Mairuhu, G., & Buijs, R. M. (2004) · Hypertension · doi:10.1161/01.hyp.0000113293.15186.3b · Cited by 451
Prolonged melatonin administration decreases nocturnal blood pressure in women
CAGNACCI, A., CANNOLETTA, M., RENZI, A., BALDASSARI, F., ARANGINO, S., & VOLPE, A. (2005) · American Journal of Hypertension · doi:10.1016/j.amjhyper.2005.05.008 · Cited by 156
Effect of melatonin on the maintenance of cholesterol homeostasis in the rat
Chan, T. Y., & Tang, P. L. (1995) · Endocrine Research · doi:10.1080/07435809509030483 · Cited by 80
Tamura, H., Nakamura, Y., Narimatsu, A., Yamagata, Y., Takasaki, A., Reiter, R. J., & Sugino, N. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00561.x · Cited by 77
Antihypertensive Action of Melatonin in the Spontaneously Hypertensive Rat
Kawashima, K., Miwa, Y., Fujimoto, K., Oohata, H., Nishino, H., & Koike, H. (1987) · Clinical and Experimental Hypertension. Part A: Theory and Practice · doi:10.3109/10641968709160037 · Cited by 75
Mullerwieland, D., Behnke, B., Koopmann, K., & Krone, W. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2198 · Cited by 64 · cited 1×
“Besides the inhibition of cholesterol absorption [17], other mechanisms may also be implicated in these effects of melatonin, including an increase in LDL receptor synthesis/activity, inhibition of cholesterol synthesis, or enhancement of cholesterol catabolism to bile acids [49, 50].”
Background
Cited by
Melatonin reprogramming of gut microbiota improves lipid dysmetabolism in high‐fat diet‐fed mice
Yin, J., Li, Y., Han, H., Chen, S., Gao, J., Liu, G., Wu, X., Deng, J., Yu, Q., Huang, X., et al. (2018) · Journal of Pineal Research · doi:10.1111/jpi.12524 · Cited by 384
Melatonin prevents obesity through modulation of gut microbiota in mice
Xu, P., Wang, J., Hong, F., Wang, S., Jin, X., Xue, T., Jia, L., & Zhai, Y. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12399 · Cited by 281
Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats
Agil, A., Rosado, I., Ruiz, R., Figueroa, A., Zen, N., & Fernández‐Vázquez, G. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00928.x · Cited by 169
Self-citationRaygan, F., Ostadmohammadi, V., Bahmani, F., Reiter, R. J., & Asemi, Z. (2019) · Clinical Nutrition · doi:10.1016/j.clnu.2017.12.004 · Cited by 147
RetractedMelatonin improves metabolic syndrome induced by high fructose intake in rats
Kitagawa, A., Ohta, Y., & Ohashi, K. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2011.00955.x · Cited by 116
Metadata
- Authors
- Agil, A., Navarro‐Alarcón, M., Ruiz, R., Abuhamadah, S., El‐Mir, M., & Vázquez, G. F.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2010-11-19
- Volume
- 50
- Issue
- 2
- Pages
- 207-212
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W1830407259
- Cited by
- 168
- References
- 6
- FWCI
- 3.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats. https://app.cochat.ai/papers/10.1111/j.1600-079x.2010.00830.x
- The paper
- Agil, A., Navarro‐Alarcón, M., Ruiz, R., Abuhamadah, S., El‐Mir, M., & Vázquez, G. F. (2011). Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats. Journal of Pineal Research. https://doi.org/10.1111/j.1600-079x.2010.00830.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.